(1 - 12 von 13
)
DGAP-Adhoc: Cytos Biotechnology AG: Cytos und Kuros Biosurgery...
www.finanznachrichten.de
· For Media Enquires: Citigate Dewe Rogerson David Dible, Sylvie Berrebi .uk +44 (0) Legal Notice: This ...
Oxurion NV – Additional Topline Data from Positive Phase 1
www.globenewswire.com
Tel: + + , Citigate Dewe Rogerson David Dible/ Sylvie Berrebi/Frazer Hall
ThromboGenics Long-time Non-executive Director Thomas Clay Appointed...
www.teletrader.com
Citigate Dewe Rogerson David Dible/Sylvie Berrebi Tel: + david ..uk .uk ...
ThromboGenics Announces FDA Acceptance of Investigational
www.globenewswire.com
, Citigate Dewe Rogerson David Dible/Sylvie Berrebi Tel: +
sortiert nach Relevanz / Datum